Autoimmune diseases as a group have reached epidemic levels in the UK with a yearly increase of 10%. This is in direct correlation with the rise in incidence of cancer. Especially after the pandemic.

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Autoimmune disease is controlled by host genes and the environment. Both can increase susceptibility to autoimmunity by affecting the overall reactivity and quality of the cells of the immune system.

Given the functional association of the lymphatics with the immune system, lymphatic dysfunction may contribute to the pathophysiology of rheumatic autoimmune diseases. Here we review the current ...

The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T therapies ...

An autoimmune disease is the result of the immune system mistakenly attacking the body’s healthy tissues. Typically, this is different from other types of immune responses, such as an allergic ...

Autoimmune disorders occur when immune cells go wrong and attack the body’s own tissues. Currently, autoimmune disorders are largely treated by broad immunosuppressive agents and blocking antibodies, ...

This is particularly true of the immune system. Autoimmune diseases show a clear predominance in women, implying a central role for estrogen in their development. A thorough elucidation of that ...

The research & development (R&D) of novel therapeutic agents for the treatment of autoimmune diseases is challenged by ... to correctly reflect the lack of response in MMPs under IL-10 overexpression, ...

Brian Setzer of the Stray Cats says he has been dealing with a health issue that has affected his ability to perform on stage ...